Subscribe To
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
LEXINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, today provided a business update and reported financial results for […] The post Keros Therapeutics Reports Recent Business Highlights and Fourth...
Read More
Posted: Mar 3 2023, 21:01
Author Name: forextv
Views: 110223